Tandem Diabetes Care Inc
NASDAQ:TNDM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tandem Diabetes Care Inc
NASDAQ:TNDM
|
US |
|
V
|
Verisk Analytics Inc
XMUN:VA7A
|
US |
|
State Bank of India
NSE:SBIN
|
IN |
|
Premier Foods PLC
LSE:PFD
|
UK |
|
Foxconn Industrial Internet Co Ltd
SSE:601138
|
CN |
|
Airbnb Inc
NASDAQ:ABNB
|
US |
|
Philogen SpA
MIL:PHIL
|
IT |
|
Polaris Media ASA
OSE:POL
|
NO |
|
Hyundai Mobis Co Ltd
KRX:012330
|
KR |
|
Bellerophon Therapeutics Inc
OTC:BLPH
|
US |
|
Vertex Resource Group Ltd
XTSX:VTX
|
CA |
|
Finexia Financial Group Ltd
ASX:FNX
|
AU |
|
M
|
Medifast Inc
DUS:MDF
|
US |
|
MSA Safety Inc
NYSE:MSA
|
US |
|
TC Energy Corp
TSX:TRP
|
CA |
|
R
|
Reckitt Benckiser Group PLC
DUS:3RB
|
UK |
|
S
|
Snowflake Inc.
F:5Q5
|
US |
Wall St Price Targets
TNDM Price Targets Summary
Tandem Diabetes Care Inc
According to Wall Street analysts, the average 1-year price target for
TNDM is 29.45 USD with a low forecast of 15.66 USD and a high forecast of 52.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TNDM's stock price target?
Price Target
29.45
USD
According to Wall Street analysts, the average 1-year price target for
TNDM is 29.45 USD with a low forecast of 15.66 USD and a high forecast of 52.5 USD.
What is the Revenue forecast for Tandem Diabetes Care Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 59%. The projected CAGR for the next 3 years is 11%.
What is the Gross Profit forecast for Tandem Diabetes Care Inc?
Projected CAGR
17%
The compound annual growth rate for Gross Profit over the next 3 years is 17%.